Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 115
Filter
Add more filters










Publication year range
1.
Circ Res ; 88(10): 1080-7, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11375279

ABSTRACT

Osteopontin (OPN), an extracellular matrix protein, is expressed in the myocardium with hypertrophy and failure. We tested the hypothesis that OPN plays a role in left ventricular (LV) remodeling after myocardial infarction (MI). Accordingly, OPN expression and LV structural and functional remodeling were determined in wild-type (WT) and OPN knockout (KO) mice 4 weeks after MI. Northern analysis showed increased OPN expression in the infarcted region, peaking 3 days after MI and gradually decreasing over the next 28 days. In the remote LV, OPN expression was biphasic, with peaks at 3 and 28 days. In situ hybridization and immunohistochemical analyses showed increased OPN mRNA and protein primarily in the interstitium. Infarct size, heart weight, and survival were similar in KO and WT mice after MI (P=NS), whereas the lung wet weight/dry weight ratio was increased in the KO mice (P<0.005 versus sham-operated mice). Peak LV developed pressure was reduced to a similar degree after MI in the KO and WT mice. The number of terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive myocytes was similar in KO and WT mice after MI. In contrast, post-MI LV chamber dilation was approximately twice as great in KO versus WT mice (P<0.001). Myocyte length increased after MI in WT mice (P<0.001) but not in KO mice. Electron microscopy showed increased collagen content in WT mice after MI but not in KO mice after MI. Type I collagen content was increased approximately 3-fold and approximately 7-fold in remote and infarcted regions, respectively, of WT hearts after MI but not in KO hearts (P<0.01 versus WT hearts). Likewise, Northern analyses showed increased collagen I(alpha(1)) mRNA after MI in remote regions of WT hearts but not in KO hearts. Thus, increased OPN expression plays an important role in regulating post-MI LV remodeling, at least in part, by promoting collagen synthesis and accumulation.


Subject(s)
Collagen/metabolism , Dilatation, Pathologic/physiopathology , Myocardial Infarction/metabolism , Sialoglycoproteins/deficiency , Ventricular Remodeling , Animals , Cardiac Volume , Cell Size , Collagen/genetics , Collagen/ultrastructure , Dilatation, Pathologic/etiology , Dilatation, Pathologic/pathology , Disease Models, Animal , Immunohistochemistry , In Situ Hybridization , In Situ Nick-End Labeling , In Vitro Techniques , Lung/pathology , Mice , Mice, Inbred Strains , Mice, Knockout , Myocardial Infarction/complications , Myocardial Infarction/physiopathology , Myocardium/metabolism , Myocardium/pathology , Myocardium/ultrastructure , Organ Size , Osteopontin , RNA, Messenger/metabolism , Sialoglycoproteins/genetics , Sialoglycoproteins/metabolism , Survival Rate , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/physiopathology
2.
Hypertension ; 35(6): 1203-9, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10856264

ABSTRACT

Inotropic responsiveness to beta-adrenergic stimulation is generally found to be impaired in left ventricular (LV) hypertrophy and failure. To investigate the mechanisms by which angiotensin-converting enzyme inhibitor therapy may modulate inotropic responsiveness with long-term pressure overload, we studied the effects of captopril treatment on cardiac gene expression, LV muscle mechanical contraction, and intracellular calcium (Ca(2+)) transients from spontaneously hypertensive rats (SHR). LV papillary muscles from untreated SHR, age-matched normotensive Wistar-Kyoto rats (WKY), and SHR treated with captopril (CAP(Rx) started at 12, 18, and 21 months of age) were studied. All animals were studied at 24 months of age or when heart failure developed. In untreated SHR, alpha-myosin heavy chain (MHC) gene expression and protein were decreased, the Ca(2+) transient (with the bioluminescent indicator aequorin) was prolonged, and abundance of Na(+)/Ca(2+) exchanger mRNA levels increased in comparison to WKY. Active stress development at L(max) and the maximum rate of stress development were depressed and contractile duration prolonged in SHR relative to WKY. Isoproterenol administration further decreased active stress in untreated SHR despite an increase in intracellular Ca(2+) levels. In CAP(Rx) SHR, alpha-MHC gene expression and protein levels were increased, the Ca(2+) transient was not prolonged, Na(+)/Ca(2+) exchanger expression was downregulated, and papillary muscle function demonstrated increased active stress and maximum rate of stress development in response to isoproterenol. The increased abundance of alpha-MHC mRNA in conjunction with an increase in V(1) myosin isozyme suggests that captopril affects transcriptional regulation of cardiac gene expression. Restored LV inotropic responsiveness to beta-adrenergic stimulation in CAP(Rx) SHR appears to be coupled to normalization of Na(+)/Ca(2+) exchanger mRNA expression, upregulation of V(1) myosin isozyme levels, and increased speed of contraction.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Captopril/pharmacology , Cardiomegaly/genetics , Cardiomegaly/physiopathology , Gene Expression/drug effects , Myocardial Contraction/drug effects , Adrenergic beta-Agonists/pharmacology , Animals , Blood Pressure/drug effects , Calcium/metabolism , Intracellular Membranes/metabolism , Isoproterenol/pharmacology , Male , Myocardium/metabolism , Myosin Heavy Chains/metabolism , Myosins/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Sodium-Calcium Exchanger/metabolism
3.
Cardiovasc Res ; 46(2): 239-49, 2000 May.
Article in English | MEDLINE | ID: mdl-10773227

ABSTRACT

Impaired functional performance despite hypertrophic enlargement, and an excessive accumulation of extracellular matrix, are hallmarks of the decompensated failing heart. Age is the leading risk factor for heart failure, and there is evidence suggesting that a number of age-associated changes in the cardiac phenotype predispose the heart to failure. The spontaneously hypertensive rat (SHR) exhibits compensated cardiac hypertrophy followed by a transition to heart failure in the last quartile of the lifespan, and thus provides a useful model of the transition from stable compensated hypertrophy to decompensated heart failure in the context of aging. The transition to failure in the SHR is accompanied by marked changes in the expression of an array of genes in the heart, including increased expression of a number of genes associated with the extracellular matrix. Drug treatments that prevent or reverse matrix gene expression in the SHR heart improve myocardial function and survival. The aged SHR model of decompensated heart failure has provided insight into the role of the extracellular matrix in the transition to failure, and can be useful to further investigate the mechanistic bases of heart failure, as well as to evaluate the potential efficacy of novel therapeutic approaches to the treatment of heart failure.


Subject(s)
Aging/metabolism , Disease Models, Animal , Extracellular Matrix/metabolism , Heart Failure/metabolism , Myocardium/metabolism , Rats, Inbred SHR , Animals , Cardiomegaly/metabolism , Gene Expression , Heart Failure/drug therapy , Rats
4.
Hypertension ; 33(1): 60-5, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9931082

ABSTRACT

-The aging spontaneously hypertensive rat (SHR) is a model in which the transition from chronic stable left ventricular hypertrophy to overt heart failure can be observed. Although the mechanisms for impaired function in hypertrophied and failing cardiac muscle from the SHR have been studied, none accounts fully for the myocardial contractile abnormalities. The cardiac cytoskeleton has been implicated as a possible cause for myocardial dysfunction. If an increase in microtubules contributes to dysfunction, then myocardial microtubule disruption by colchicine should promote an improvement in cardiac performance. We studied the active and passive properties of isolated left ventricular papillary muscles from 18- to 24-month-old SHR with evidence of heart failure (SHR-F, n=6), age-matched SHR without heart failure (SHR-NF, n=6), and age-matched normotensive Wistar-Kyoto rats (WKY, n=5). Mechanical parameters were analyzed before and up to 90 minutes after the addition of colchicine (10(-5), 10(-4), and 10(-3) mol/L). In the baseline state, active tension (AT) developed by papillary muscles from the WKY group was greater than for SHR-NF and SHR-F groups (WKY 5.69+/-1.47 g/mm2 [mean+/-SD], SHR-NF 3.41+/-1.05, SHR-F 2.87+/-0.26; SHR-NF and SHR-F P<0.05 versus WKY rats). The passive stiffness was greater in SHR-F than in the WKY and SHR-NF groups (central segment exponential stiffness constant, Kcs: SHR-F 70+/-25, SHR-NF 44+/-17, WKY 41+/-13 [mean+/-SD]; SHR-F P<0.05 versus SHR-NF and WKY rats). AT did not improve after 10, 20, and 30 minutes of exposure to colchicine (10(-5), 10(-4), and 10(-3) mol/L) in any group. In the SHR-F group, AT and passive stiffness did not change after 30 to 90 minutes of colchicine exposure (10(-4) mol/L). In summary, the data in this study fail to demonstrate improvement of intrinsic muscle function in SHR with heart failure after colchicine. Thus, in the SHR there is no evidence that colchicine-induced cardiac microtubular depolymerization affects the active or passive properties of hypertrophied or failing left ventricular myocardium.


Subject(s)
Colchicine/pharmacology , Gout Suppressants/pharmacology , Heart Failure/physiopathology , Heart/drug effects , Hypertrophy, Left Ventricular/physiopathology , Myocardial Contraction/drug effects , Animals , Blotting, Western , Data Interpretation, Statistical , Histological Techniques , In Vitro Techniques , Male , Models, Cardiovascular , Papillary Muscles/drug effects , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Tubulin/analysis
5.
Hypertension ; 33(2): 663-70, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10024324

ABSTRACT

To identify genes that are differentially expressed during the transition from compensated hypertrophy to failure, myocardial mRNA from spontaneously hypertensive rats (SHR) with heart failure (SHR-F) was compared with that from age-matched SHR with compensated hypertrophy (SHR-NF) and normotensive Wistar-Kyoto rats (WKY) by differential display reverse transcriptase-polymerase chain reaction. Characterization of a transcript differentially expressed in SHR-F yielded a cDNA with homology to the extracellular matrix protein osteopontin. Northern analysis showed low levels of osteopontin mRNA in left ventricular myocardium from WKY and SHR-NF but a markedly increased (approximately 10-fold) level in SHR-F. In myocardium from WKY and SHR-NF, in situ hybridization showed only scant osteopontin mRNA, primarily in arteriolar cells. In SHR-F, in situ hybridization revealed abundant expression of osteopontin mRNA, primarily in nonmyocytes in the interstitial and perivascular space. Similar findings for osteopontin protein were observed in the midwall region of myocardium from the SHR-F group. Consistent with the findings in SHR, osteopontin mRNA was minimally increased (approximately 1.9-fold) in left ventricular myocardium from nonfailing aortic-banded rats with pressure-overload hypertrophy but was markedly increased (approximately 8-fold) in banded rats with failure. Treatment with captopril starting before or after the onset of failure in the SHR reduced the increase in left ventricular osteopontin mRNA levels. Thus, osteopontin expression is markedly increased in the heart coincident with the development of heart failure. The source of osteopontin in SHR-F is primarily nonmyocytes, and its induction is inhibited by an angiotensin-converting enzyme inhibitor, suggesting a role for angiotensin II. Given the known biological activities of osteopontin, including cell adhesion and regulation of inducible nitric oxide synthase gene expression, these data suggest that it could play a role in the pathophysiology of heart failure.


Subject(s)
Heart Failure/metabolism , Hypertension/complications , Sialoglycoproteins/biosynthesis , Animals , Base Sequence , DNA, Complementary/genetics , Gene Expression Regulation , Hypertension/metabolism , Immunohistochemistry , Molecular Sequence Data , Myocardium/metabolism , Osteopontin , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Sialoglycoproteins/genetics
6.
J Mol Cell Cardiol ; 30(7): 1257-62, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9710794

ABSTRACT

A two-order-magnitude increase in the expression of an endogenous retrovirus was found in myocytes from spontaneously hypertensive rats (SHR) relative to Wistar-Kyoto rats (WKY). It has now been demonstrated that the increase in proviral transcripts is not secondary to the effects of pressure overload, as WKY hearts with hypertrophy due to aortic banding do not express the retrovirus. Crossing SHR with WKY results in intermediate levels of blood pressure, hypertrophy and retroviral gene expression, suggesting co-segregation of genotype and phenotype. Findings suggest a possible linkage between an endogenous retrovirus and genetic hypertension in the SHR. A brief overview of endogenous retroviruses is presented and a discussion of their potential for inducing cardiovascular pathology is considered.


Subject(s)
Cardiovascular Diseases/virology , Retroviridae/physiology , Animals , DNA Transposable Elements , Humans , Rats , Rats, Inbred SHR , Retroviridae/genetics
7.
Hypertension ; 30(6): 1362-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9403554

ABSTRACT

The spontaneously hypertensive rat (SHR) exhibits a transition from stable compensated left ventricular (LV) hypertrophy to heart failure (HF) at a mean age of 21 months that is characterized by a decrease in alpha-myosin heavy chain (alpha-MHC) gene expression and increases in the expression of the atrial natriuretic factor (ANF), pro-alpha1(III) collagen, and transforming growth factor beta1 (TGF-beta1) genes. We tested the hypotheses that angiotensin-converting enzyme inhibition (ACEI) in SHR would prevent and reverse HF-associated changes in gene expression when administered prior to and after the onset of HF, respectively. We also investigated the effect of ACEI on circulating and cardiac components of the renin-angiotensin system. ACEI (captopril 2 g/L in the drinking water) was initiated at 12, 18, and 21 months of age in SHR without HF and in SHR with HF. Results were compared with those of age-matched normotensive Wistar-Kyoto (WKY) rats, and to untreated SHR with and without evidence of HF. ACEI initiated prior to failure prevented the changes in alpha-MHC, ANF, pro-alpha1(III) collagen, and TGF-beta1 gene expression that are associated with the transition to HF. ACEI initiated after the onset of HF lowered levels of TGF-beta1 mRNA by 50% (P<.05) and elevated levels of alpha-MHC mRNA two- to threefold (P<.05). Circulating levels of renin and angiotensin I were elevated four- to sixfold by ACEI, but surprisingly, plasma levels of angiotensin II were not reduced. ACEI increased LV renin mRNA levels in WKY and SHR by two- to threefold but did not influence LV levels of angiotensinogen mRNA. The results suggest that the anti-HF benefits of ACEI in SHR may be mediated, at least in part, by effects on the expression of specific genes, including those encoding alpha-MHC, ANF, TGF-beta1, pro-alpha1(III) collagen, and renin-angiotensin system components.


Subject(s)
Aging/physiology , Captopril/pharmacology , Cardiomegaly/metabolism , Gene Expression Regulation/drug effects , Heart Failure/physiopathology , Heart/physiopathology , Hypertension/physiopathology , Renin/biosynthesis , Analysis of Variance , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensinogen/biosynthesis , Animals , Atrial Natriuretic Factor/biosynthesis , Cardiomegaly/physiopathology , Heart/growth & development , Heart/physiology , Heart Failure/metabolism , Hypertension/metabolism , Male , Myosin Heavy Chains/biosynthesis , Polymerase Chain Reaction , RNA, Messenger/analysis , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Transcription, Genetic , Transforming Growth Factor beta/biosynthesis
8.
Circulation ; 96(11): 4002-10, 1997 Dec 02.
Article in English | MEDLINE | ID: mdl-9403625

ABSTRACT

BACKGROUND: After a period of stable hypertrophy, male spontaneously hypertensive rats (SHR) develop heart failure between 18 to 24 months of age, with depression of active myocardial function and increased passive stiffness. We tested the hypothesis that chronic ACE inhibition by captopril would prevent and possibly reverse impairment of myocardial function. METHODS AND RESULTS: Male SHR and normotensive Wistar-Kyoto rats (WKY) were assigned to no treatment or captopril treatment (2 g/L in drinking water) begun at ages 12, 18, and 21 months; animals were studied at 24 months of age, or earlier when evidence of heart failure was found in SHR (mean age, 19+/-2 months). In an additional group, captopril treatment was begun when SHR developed heart failure; surviving animals were studied at 24 months of age. In untreated SHR, relative to WKY, isometric stress development at Lmax, maximum rate of stress development, and shortening velocity were depressed, whereas passive stiffness was increased, in association with the development of myocardial fibrosis. In the SHR treated before cardiac dysfunction, captopril administration attenuated hypertrophy and prevented contractile dysfunction, fibrosis, and increased passive stiffness. Captopril treatment begun after cardiac function was impaired reduced left ventricular hypertrophy but did not restore intrinsic contractile function or reduce fibrosis or passive stiffness. CONCLUSIONS: In the male SHR, early treatment with captopril was associated with the most marked attenuation of dysfunction relative to the untreated SHR. Treatment initiated after the onset of heart failure improved clinical signs of heart failure and decreased left ventricular hypertrophy in surviving animals but did not reverse the fibrosis and contractile dysfunction associated with heart failure.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Captopril/pharmacology , Cardiac Output, Low/physiopathology , Heart/drug effects , Myocardial Contraction/drug effects , Animals , Blood Pressure , Body Weight , Cardiac Output, Low/diagnostic imaging , Cardiac Output, Low/etiology , Cardiac Output, Low/pathology , Echocardiography , Heart/physiopathology , Male , Myocardium/pathology , Organ Size , Rats , Rats, Inbred SHR , Rats, Inbred WKY
9.
Arq. bras. cardiol ; 69(6): 381-4, dez. 1997. tab
Article in Portuguese | LILACS | ID: lil-234369

ABSTRACT

OBJETIVO - Avaliar a participação do estado contrátil e do relaxamento miocárdico na disfunção do músculo cardíaco durante a transição hipertrofia-falência cardíaca em ratos espontaneamente hipertensos (SHR). MÉTODOS - Músculos papilares isolados do ventrículo esquerdo de SHR com insuficiência cardíaca (SHR-IC) e sem falência (SHR) e de ratos normotensos controle Wistar-Kyoto (WKY) foram estudados em contraçöes isométrica e isotônica, em solução de Krebs-Henseleit (1,25 mM Ca 'elevado a +2', 28 'graus Celsius'). RESULTADOS - Os valores da tensão máxima desenvolvida (TD) e da velocidade máxima de encurtamenton (V máx) foram menores nos SHR-IC e SHR, em relação aos WKY (p<0,05). TD e V máx foram semelhantes nos SHR-IC e SHR (p>0,05). A rigidez passiva do músculo aumentou significantemente nos SHR-IC (p<0,05 vs WKY e SHR); esta variável não diferiu entre WKY e SHR (p>0,05). CONCLUSÄO - Os dados obtidos mostram que a transição da fase de hipertrofia estável para insuficiência cardíaca nos ratos espontaneamente hipertensos está associado ao aumento da rigidez passiva do miocárdio e näo à piora da funçäo contrátil do músculo cardíaco.


Subject(s)
Humans , Animals , Infant , Rats , Cardiac Output, Low , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , In Vitro Techniques , Myocardial Contraction , Animal Testing Alternatives , Body Weight , Rats, Inbred SHR , Time Factors
10.
J Mol Cell Cardiol ; 29(9): 2335-44, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9299357

ABSTRACT

Spontaneously hypertensive rats (SHR) commonly develop impairment of myocardial function between ages 18-24 months. Isolated muscle studies demonstrate depressed myocardial contractility and increased passive stiffness. Studies of the extracellular matrix in SHR with failure (SHR-F) demonstrate an increased expression of genes encoding extracellular matrix components (ECM), hydroxyproline concentration and fibrosis relative to age-matched non-failing animals. In the present study, tissue sections of hearts from SHR-F, non-failing SHR (SHR-NF) and non-hypertensive Wistar Kyoto rats (WKY) were hybridized with a cDNA probe for alpha1(I) collagen mRNA, which was found by Northern blot analysis to be elevated in SHR-F relative to hearts from control animals. In situ hybridization studies demonstrate increased perivascular and interstitial collagen alpha1(I) gene expression in myocardium from the SHR relative to WKY. In addition, failing hearts from the SHR demonstrate focal alpha1(I) collagen mRNA accumulation in the endocardium and at sites of degenerating single myocardial cells.


Subject(s)
Cardiomegaly/metabolism , Collagen/genetics , Heart Failure/metabolism , Myocardium/metabolism , Myocardium/pathology , Animals , Blotting, Northern , Cardiomegaly/physiopathology , In Situ Hybridization , Male , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR , Rats, Inbred WKY
11.
Hypertension ; 30(1 Pt 1): 88-93, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9231826

ABSTRACT

The spontaneously hypertensive rat (SHR) is a well studied animal model of genetic hypertension and heart disease of unknown cause. With the use of differential display, a transcript was found in SHR myocardium that on sequence analysis was identified as an endogenous retrovirus (ERV). ERV gene expression was greater than an order of magnitude increased in adult SHR hearts relative to age-matched normotensive Wistar-Kyoto rats and was further increased in hearts from SHR with heart failure. In situ hybridization studies demonstrated that increased ERV gene expression was localized to myocardial cells. Increases in ERV transcripts in SHR suggest a possible link between inherited proviral elements and genetic hypertensive heart disease.


Subject(s)
Heart/virology , Hypertension/genetics , Myocardium/metabolism , Retroviridae/genetics , Transcription, Genetic , Age Factors , Analysis of Variance , Animals , Autoradiography , Blotting, Northern , Heart Failure/genetics , Histological Techniques , In Situ Hybridization , Male , Molecular Sequence Data , Myocardium/cytology , Polymerase Chain Reaction , RNA, Viral/analysis , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Retroviridae/isolation & purification , Sequence Analysis, RNA
12.
Am J Physiol ; 272(5 Pt 2): H2313-9, 1997 May.
Article in English | MEDLINE | ID: mdl-9176300

ABSTRACT

The transition from compensated hypertrophy to failure in spontaneously hypertensive rats (SHR) of advanced age is associated with a marked increase in collagen, a reduction in myocyte mass, and a reduction in maximum Ca(2+)-activated myofibrillar force. We hypothesized that the reduction in myocyte mass and associated functional loss may be due to increased cell death by apoptosis. To test this hypothesis, we studied hearts from failing (SHR-F) and nonfailing SHR (SHR-NF) and age-matched Wistar-Kyoto rats (WKY). In addition, hearts from SHR-F that had been treated with an angiotensin-converting enzyme inhibitor (captopril) for an average of 27 days were also studied. Apoptotic cells were quantified in cross sections of myocardium by the terminal deoxynucleotidyltransferase- mediated 2'-deoxyuridine 5'-triphosphate nick end labeling technique. To identify the type of the cells undergoing apoptosis, sections were also stained for alpha-sarcomeric actin. Apoptotic cells were significantly increased in the SHR-F (38.92 +/- 12.79 vs. 8.05 +/- 3.98 cells/100,000 nuclei in SHR-NF; P < 0.05 and vs. 2.21 +/- 1.4 cells/100,000 nuclei in WKY; P < 0.01). Captopril treatment of SHR-F reduced the number of apoptotic cells to the level in SHR-NF (9.17 +/- 1.53 cells/100,000 nuclei; P < 0.01 vs. SHR-F). Most apoptotic cells were of cardiac myocyte origin. There was no significant difference in Bcl-2 protein expressed by hearts among the three groups. WAF-1 mRNA levels were increased in both SHR groups vs. WKY; in SHR-F, the density of WAF-1 mRNA was higher than in SHR-NF. Thus increased numbers of apoptotic cells are present in failing SHR hearts, suggesting that apoptosis might be a mechanism involved in the reduction of myocyte mass that accompanies the transition from stable compensation to heart failure in this model. Administration of the angiotensin-converting enzyme inhibitor captopril, which ameliorates heart failure in this model, is associated with a reduction in the exaggerated apoptosis that accompanies heart failure.


Subject(s)
Apoptosis , Heart Failure/pathology , Myocardium/pathology , Rats, Inbred SHR/anatomy & histology , Receptors, Angiotensin/physiology , Angiotensin II/pharmacology , Animals , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , DNA Fragmentation , Gene Expression , Hypertension/pathology , Myocardium/metabolism , RNA, Messenger/genetics , Rats , Rats, Inbred WKY , Receptor, Angiotensin, Type 2
13.
Mol Cell Biochem ; 166(1-2): 45-54, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9046020

ABSTRACT

Colchicine has been demonstrated to suppress the release of fibroblast growth factors, retard collagen formation and augment collagenase activity. Trials with colchicine in patients with hepatic fibrosis have suggested clinical benefit. The development of impaired myocardial function in the spontaneously hypertensive rat (SHR) is associated with a marked increase in myocardial fibrosis. The present study was carried out to test the hypothesis that chronic colchicine administration to the SHR would prevent the development of fibrosis and impaired myocardial performance. Colchicine (1 mg/l drinking water) was administered to male SHR and WKY rats from at age 13 months until 24 months or until evidence of heart failure was observed. Age-matched untreated SHR and colchicine treated and untreated WKY served as controls. At study, active and passive properties of isolated left ventricular muscle preparations were determined. Myocardial fibrosis was assessed by measuring hydroxyproline and histologic determination of interstitial cross-sectional area. Increases in LV hydroxyproline and interstitial area were found in untreated SHR relative to WKY; passive myocardial stiffness was increased and active muscle properties were depressed. In comparing colchicine treated vs untreated SHR, no differences in hydroxyproline, interstitial area or intrinsic myocardial function were found. In the WKY, colchicine increased myocardial interstitium and passive stiffness without changing hydroxyproline. Active myocardial function was not depressed. Thus, chronic colchicine administration neither attenuated the development of interstitial fibrosis nor prevented impaired myocardial function in the SHR. Colchicine treatment was associated with increased interstitium in WKY with increased passive myocardial stiffness.


Subject(s)
Colchicine/pharmacology , Heart/drug effects , Hypertension/physiopathology , Aging , Animals , Disease Models, Animal , Fibrosis , Heart/physiopathology , Hydroxyproline/analysis , Hypertension/pathology , Male , Muscle Contraction/drug effects , Myocardium/chemistry , Myocardium/pathology , Rats , Rats, Inbred SHR , Rats, Inbred WKY
14.
Arq Bras Cardiol ; 69(6): 381-4, 1997 Dec.
Article in Portuguese | MEDLINE | ID: mdl-9609008

ABSTRACT

PURPOSE: To investigate the participation of contractile state and relaxation in cardiac muscle dysfunction during the transition from stable hypertrophy to cardiac decompensation in aging spontaneously hypertensive rats (SHR). METHODS: Isolated left ventricular papillary muscle function was studied in SHR with heart failure (SHR-F), in age-matched SHR without evidence of heart failure (SHR-NF), and in nonhypertensive controls Wistar-Kyoto rats (WKY). Muscles were analysed in isometric and isotonic contractions in Krebs-Henseleit solution with calcium concentration of 1.25 mM at 28 degrees C. RESULTS: Papillary muscles from SHR-F and SHR-NF demonstrated decreased active tension development and shortening velocity relative to normotensive WKY (p < 0.05). SHR-F and SHR-NF did not differ. Compared with SHR-NF and WKY, muscle passive stiffness was increased in the failing SHR (p < 0.05 versus WKY and SHR-NF). This parameter did not differ between SHR-NF and WKY (p > 0.05). CONCLUSION: These data suggest that the progression from stable hypertrophy to heart failure is associated with changes in the passive stiffness and is not related to depression of myocardial contractile function.


Subject(s)
Cardiac Output, Low/physiopathology , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Myocardial Contraction/physiology , Ventricular Dysfunction, Left/physiopathology , Animals , Cardiac Output, Low/etiology , Hypertrophy, Left Ventricular/complications , Hypertrophy, Right Ventricular/complications , Male , Rats , Rats, Inbred WKY
15.
Cardiovasc Res ; 32(6): 1038-46, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9015406

ABSTRACT

OBJECTIVE: To examine the basis for local wall motion abnormalities commonly seen in patients with ischemic heart disease, computer-controlled isolated muscle studies were carried out. METHODS: Force patterns of physiologically sequenced contractions (PSCs) from rat left ventricular muscle preparations under well-oxygenated conditions and during periods of hypoxia and reoxygenation were recorded and stored in a computer. Force patterns of hypoxic-reoxygenating and oxygenated myocardium were applied to oxygenated and hypoxic-reoxygenating myocardium, respectively. RESULTS: Observed patterns of shortening and lengthening closely resemble those obtained from ischemic and non-ischemic myocardial segments using ultrasonic crystals in intact dog hearts during coronary occlusion and reperfusion, and are similar to findings reported in angiographic studies of humans with coronary artery disease. CONCLUSION: The current study, demonstrating motions of oxygenated isolated muscle preparations which are similar to those in perfused segments of intact hearts with regional ischemia, supports the concept that the multiple motions of both ischemic and non-ischemic segments seen in regional myocardial disease can be explained by interactions of strongly and weakly contracting muscle during the physiologic cardiac cycle.


Subject(s)
Myocardial Contraction/physiology , Myocardial Ischemia/physiopathology , Animals , In Vitro Techniques , Male , Minicomputers , Myocardial Reperfusion , Papillary Muscles/physiopathology , Rats , Rats, Inbred Strains
16.
Biochem Biophys Res Commun ; 218(1): 320-4, 1996 Jan 05.
Article in English | MEDLINE | ID: mdl-8573154

ABSTRACT

To examine differences in cardiac gene expression between spontaneously hypertensive rats with and without heart failure, we have used subtractive hybridization to identify differentially expressed genes. After subtraction, cDNAs were amplified by PCR, cloned and sequenced. One of 36 independent cDNAs was found to be 86% homologous to murine UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase. RNA blot analysis confirmed the approximately 4.0 kb rat galactosyltransferase transcript was increased in failing hearts relative to non-failing hearts. Biochemical assay also showed increased galactosyltransferase activity in the failing hearts.


Subject(s)
Cardiomegaly/enzymology , Gene Expression , Heart Failure/enzymology , Myocardium/enzymology , N-Acetyllactosamine Synthase/biosynthesis , Amino Acid Sequence , Animals , Base Sequence , Cardiomegaly/pathology , DNA, Complementary , Male , Mice , Molecular Sequence Data , Myocardium/cytology , Myocardium/pathology , Oligodeoxyribonucleotides , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Reference Values , Sequence Homology, Nucleic Acid
17.
Eur Heart J ; 16 Suppl N: 19-30, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8682057

ABSTRACT

Spontaneously hypertensive rats (SHR) of advanced age exhibit depressed myocardial contractile function and ventricular fibrosis, as stable compensated hypertrophy progresses to heart failure. Transition to heart failure in SHR aged 18-24 months was characterized by impaired left ventricular (LV) function, ventricular dilatation, and reduced ejection fraction without an increase in LV mass. Studies of papillary muscles from SHR with failing hearts (SHR-F), SHR without failure (SHR-NF), and age-matched Wistar Kyoto (WKY) rats allowed examination of changes in the mechanical properties of myocardium during the transition to heart failure. Papillary muscles of SHR-F exhibited increased fibrosis, impaired contraction, and decreased myocyte fractional area. These findings in papillary muscles were correlated with a higher concentration of hydroxyproline and increased histological evidence of fibrosis in the LV free wall. While a depression in active tension accompanied these structural alterations in papillary muscles, it was not evident when active tension was normalized to myocyte fractional area. Together, these data suggest that individual myocyte function may be preserved but that myocyte loss and replacement by extracellular matrix contribute substantially to the decrement in active tension. An absent or negative inotropic response to isoproterenol is observed in SHR-F and SHR-NF papillary muscles and may result in part from age-related alterations in beta-adrenergic receptor dynamics and a shift from alpha- to beta-myosin heavy chain (MHC) protein. During the transition to failure, ventricles of SHR exhibit a marked increase in collagen and fibronectin mRNA levels, suggesting that an increase in the expression of specific extracellular matrix genes may contribute to fibrosis, tissue stiffness, and impaired function. Transforming growth factor-beta 1 (TGF-beta 1) mRNA levels also increase in SHR-F, consistent with the concept that TGF-beta 1 plays a key regulatory role in remodelling of the extracellular matrix gene during the transition to failure. The renin-angiotensin-aldosterone system is also implicated in the transition to failure: SHR treated with the angiotensin converting enzyme inhibitor captopril starting at 12 months of age did not develop heart failure during the 18-24 month observation period. Captopril treatment that was initiated after rats were identified with evidence of failure led to a reappearance of alpha-MHC mRNA but did not improve papillary muscle function. Research opportunities include investigation of apoptosis as a mechanism of cell loss, delineation of the regulatory roles of TGF-beta 1 and the renin-angiotensin-aldosterone system in matrix accumulation, and studies of proteinase cascades that regulate matrix remodelling.


Subject(s)
Cardiomegaly/physiopathology , Heart Failure/physiopathology , Hypertension/physiopathology , Age Factors , Animals , Cardiomegaly/pathology , Endomyocardial Fibrosis/pathology , Endomyocardial Fibrosis/physiopathology , Extracellular Matrix/pathology , Extracellular Matrix/physiology , Heart Failure/pathology , Hemodynamics/physiology , Hypertension/pathology , Myocardial Contraction/physiology , Myocardium/pathology , Rats , Rats, Inbred SHR , Rats, Inbred WKY
19.
Am Heart J ; 130(4): 922-32, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7572610

ABSTRACT

The objective of the current editorial is to introduce a new concept ("maimed myocardium") that we believe describes more accurately the incomplete, delayed recovery of LV function that may occur late after reperfusion after AMI. It has been demonstrated previously that myocardium remains viable for a prolonged period in many patients with nonsustained coronary occlusion, despite the occurrence of myocardial necrosis; late reperfusion may result in myocardial salvage in reversibly ischemic (stunned) segments (complete recovery) and in intensely injured (maimed) segments that display partial return of LV function over time (incomplete recovery). Clinically, the basis for maimed myocardium is the observation that delayed, LV functional recovery may occur in partially infarcted segments where there has been an antecedent ischemic insult of sufficient duration to result in some degree of myocardial necrosis. Certain acute coronary syndromes characterized by nonsustained coronary occlusion followed by spontaneous reperfusion (e.g., non-Q-wave AMI) or drug-induced reperfusion induced by the exogenous administration of thrombolytic therapy are associated with incomplete, delayed recovery of LV function as detected clinically by partial improvement in serial radionuclide-ejection measurement, enhanced metabolic integrity of cardiac tissue by F-18 deoxyglucose myocardial imaging, and scintigraphic findings of reverse thallium redistribution--findings that support the presence of partially viable myocardium that has been incompletely salvaged during reperfusion late after AMI. Experimentally, delayed LV functional recovery has been reported in animal models in which prolonged coronary occlusion (hours to days) followed by reperfusion is associated with late recovery of regional LV function in myocardial segments subtending border (stunned) zones and central infarct (maimed) zones. In studies in animals and human beings, postextrasystolic potentiation and pharmacologic inotropic interventions may augment maimed and stunned segments, although the magnitude of regional contractile reserve that can be unmasked with these interventions is quantitatively less in the maimed than in stunned segments. In summary, the propensity of intensely injured or partially infarcted LV segments to display intermediate functional recovery followed by reperfusion late after coronary occlusion suggests that even severely depressed but residually viable cardiac muscle can be salvaged incompletely over time.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Myocardial Infarction/physiopathology , Myocardial Reperfusion Injury , Ventricular Dysfunction, Left/physiopathology , Animals , Humans , Myocardial Reperfusion Injury/pathology , Myocardial Reperfusion Injury/physiopathology , Myocardial Stunning , Time Factors
20.
Hypertension ; 26(1): 78-82, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7607736

ABSTRACT

Inotropic responsiveness to beta-adrenergic stimulation is generally found to be depressed in cardiac hypertrophy and failure. To investigate whether inotropic responsiveness is associated with alterations in beta-adrenergic receptors in spontaneously hypertensive rats (SHR), we studied left ventricular myocardial contractile responses to isoproterenol and beta-adrenergic receptor density and affinity in age-matched rats (18 to 24 months), including SHR without heart failure, SHR with evidence of heart failure, and normotensive control Wistar-Kyoto rats (WKY). In the baseline state, papillary muscles from failing SHR demonstrated decreased isometric tension development and a reduction in maximal rate of tension development relative to normotensive WKY and compensated SHR. Compared with WKY, beta-adrenergic receptor density of the left ventricle was unchanged in nonfailing SHR and increased in failing SHR (P < .05 versus WKY and nonfailing SHR), and beta-adrenergic receptor affinity did not differ among groups. In the right ventricle, beta-adrenergic receptor density was decreased in failing SHR relative to WKY and nonfailing SHR, and beta-adrenergic receptor affinity was not different among groups. Muscle preparations did not exhibit a positive inotropic response to 10(-8) to 10(-5) mol/L isoproterenol or 6.3 mumol/L forskolin in either failing or nonfailing SHR, whereas a positive inotropic response to both drugs was observed in the normotensive WKY. The lusitropic response to isoproterenol and forskolin was intact and similar in both SHR groups and WKY. The findings suggest that in the SHR model of heart failure, impaired intrinsic left ventricular myocardial function and depressed inotropic responsiveness to beta-adrenergic stimulation are not associated with downregulation of the beta-adrenergic receptor.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Heart Failure/physiopathology , Hypertension/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Receptors, Adrenergic, beta/drug effects , Animals , Biochemical Phenomena , Biochemistry , Colforsin/pharmacology , Heart Ventricles/metabolism , In Vitro Techniques , Isometric Contraction , Isoproterenol/pharmacology , Male , Myocardial Contraction/drug effects , Papillary Muscles/chemistry , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptors, Adrenergic, beta/metabolism , Receptors, Adrenergic, beta/physiology , Stimulation, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...